Sultan Pharmaceuticals Private Limited
About Sultan Pharmaceuticals Private Limited
Data last updated:
Sultan Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 01 February 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC159255.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Samba Siva Rao Nerella and Dhana Lakshmi Nerella.
Its last annual general meeting (AGM) was held on 03 November 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H.No.8 – 2 – 629/K Shivalik Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2023, the company reported a revenue of ₹73.36 Lakh. For the same year it recorded a net profit of ₹70,622 (net margin 1%) and EBITDA of ₹1.29 Lakh (EBITDA margin 1.8%).
Company details
Contact details
Sultan Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH.No.8 – 2 – 629/K Shivalik Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sultan Pharmaceuticals Private Limited
FY 2023 filings availableSultan Pharmaceuticals Private Limited reported revenue of ₹73.36 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.29 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹70,622 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.8% | |
| Net Profit Margin | 1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sultan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sultan Pharmaceuticals Private Limited
Sultan Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samba Siva Rao Nerella | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Dhana Lakshmi Nerella Also directs: Quadbase India Private Limited, Sultan Diagnostics Private Limited | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Sultan Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunovion Pharmaceuticals (India) Private Limited | ₹73.66 Lakh (FY 2025) | 80.0% | Mumbai, Maharashtra, India | |||
| Sickcure Pharmaceuticals Private Limited | ₹73.64 Lakh (FY 2024) | -19.0% | Paontasahib, Himachal Pradesh, India | |||
| Rholence Pharmaceuticals Private Limited | ₹73.59 Lakh (FY 2024) | 16.0% | Nagpur, Maharashtra, India | |||
| Riksan Pharmaceuticals Private Limited | ₹73.55 Lakh (FY 2025) | 25.0% | Mangalore, Karnataka, India | |||
| Mayaan Pharmaceuticals Private Limited | ₹73.45 Lakh (FY 2024) | 76.0% | Hyderabad, Telangana, India | |||
| Sultan Pharmaceuticals Private Limitedthis company | ₹73.36 Lakh (FY 2023) | ₹70,622 | 1% | Hyderabad, Telangana, India | ||
| Enzem Pharmaceuticals Private Limited | ₹73.35 Lakh (FY 2025) | 25.0% | Bangalore, Karnataka, India | |||
| Solisky Pharmaceuticals Private Limited | ₹73.32 Lakh (FY 2025) | -12.0% | Ahmedabad, Gujarat, India | |||
| Abia Pharmaceuticals Private Limited | ₹73.13 Lakh (FY 2024) | -70.0% | Chennai, Tamil Nadu, India | |||
| Tirupati Pharmaceuticals Private Limited | ₹73.07 Lakh (FY 2021) | -30.0% | New Delhi, Delhi, India | |||
| Addicott Pharmaceuticals Private Limited | ₹73.05 Lakh (FY 2024) | 112.0% | Madhepura, Bihar, India |
To see the full peer comparison of Sultan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sultan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sultan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sultan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sultan Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Dhana Lakshmi Nerella was appointed as Director on 01 Feb 2022.
Frequently asked questions
Sultan Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under CIN U24290TG2022PTC159255.
Sultan Pharmaceuticals has 2 current directors:
- Samba Siva Rao Nerella - Director
- Dhana Lakshmi Nerella - Director
The latest financial statements of Sultan Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 03 November 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Sultan Pharmaceuticals is U24290TG2022PTC159255. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sultan Pharmaceuticals was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sultan Pharmaceuticals by revenue are Sunovion Pharmaceuticals (India) Private Limited, Sickcure Pharmaceuticals Private Limited, Rholence Pharmaceuticals Private Limited, Riksan Pharmaceuticals Private Limited, Mayaan Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Dhana Lakshmi Nerella was appointed as Director on 01 Feb 2022. Samba Siva Rao Nerella was appointed as Director on 01 Feb 2022.
The registered office of Sultan Pharmaceuticals is at H.No.8 – 2 – 629K Shivalik Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034.
Sultan Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sultan Pharmaceuticals can be reached at its registered office: H.No.8 – 2 – 629K Shivalik Plaza Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034.
Sultan Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.